Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia
Key facts
- Who runs it
- Centre Hospitalier le Mans
- Where
- France16 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 2,400 people, planned
- Started
- 7 Nov 2024
- Expected to end
- 7 Apr 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- nasogastric tube and orogastric tube
- orogastric tube and nasogastric tube
- Record updated
- 10 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- patient in intensive care, intubated, ventilated
- Adult
- Requiring a gastric tube
- With an expected duration of mechanical ventilation of more than 48 hours
- Affiliated to social security
- Patient or relative consent or, failing that, emergency inclusion of the patient
Who cannot take part
- Pregnant, breast-feeding or parturient women
- Patients under legal protection: curatorship and guardianship
- Contraindication to placing a gastric tube through the nose or mouth
- Patients who already have a gastric tube when they enter the service
- Patient intubated for more than 24 hours
- Patient intubated via the nasotracheal route
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
In intensive care, many gastric tubes are inserted on a regular basis. There are different practices in terms of the location of the gastric tube. In some cases, the tube is inserted through the nose and in others, it is inserted through the mouth.
Read full original descriptionShow less
In the literature and in practice, these gastric tubes create discomfort and complications that have an impact not only on the patient, but also on the treatments and the length of the patient's stay in hospital.
Nosocomial Ventilator Associated Pneumonia is the most serious common complication for patients intubated with a gastric tube. It is possible that placement site may have an impact on the risk of developing Ventilator Associated Pneumonia, particularly by increasing the risk of bacterial pullulation opposite the sinuses when the tube is placed via the nasal route.
Investigator hypothesises that placing the gastric tube orally will reduce the rate of ventilator-associated pneumonia compared with the nasal route in mechanically ventilated intensive care patients.
The 2 groups in the trial
- NasogastricTreatment being tested
nasogastric tube in period 1 and orogastric tube in period 2
Treatment: nasogastric tube and orogastric tube
- OrogastricTreatment being tested
orogastric tube in period 1 and nasogastric tube in period 2
Treatment: orogastric tube and nasogastric tube
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Impact of the Choice of Gastric Tube Placement Sites on the Incidence of Ventilator Associated Pneumonia and Other Complications in the Intensive Care Unit
- Publications
- Record updated
- 10 September 2026